Skip to content


You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Pharmacology and Toxicology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: a systematic review and meta-analysis of published randomized controlled trials

BMC Pharmacology and ToxicologyBMC series – open, inclusive and trusted201718:19

Received: 29 December 2016

Accepted: 28 February 2017

Published: 16 April 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
29 Dec 2016 Submitted Original manuscript
17 Jan 2017 Reviewed Reviewer Report - Emanuel Raschi
24 Jan 2017 Reviewed Reviewer Report - Elisabetta Poluzzi
3 Feb 2017 Author responded Author comments - Pravesh Bundhun
Resubmission - Version 2
3 Feb 2017 Submitted Manuscript version 2
28 Feb 2017 Editorially accepted
16 Apr 2017 Article published 10.1186/s40360-017-0126-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Institute of Cardiovascular Diseases, The First Affiliated Hospital of Guangxi Medical University
Guangxi Medical University